I used the market as a reference because of the unpredictability at times.
Past performance isn't always an indicator of future direction.
Nobody seems to be taking Titan seriously on the Parkinson's angle.
Their failure to be upfront with its investors continues to be a blemish (putting it mildly),which will only be overshadowed by Braeburn meeting their quota of patients.